Aktienanalyse zu Acadia Healthcare Company, Inc. (ACHC)ACHCAcadia Healthcare Company, Inc.

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services. The Company owns and operates acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), residential treatment centers and facilities providing outpatient behavioral healthcare services to serve the behavioral healthcare and recovery needs of communities throughout the United States and Puerto Rico. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its CTCs specialize in providing medication-assisted treatment in an outpatient setting. Its specialty treatment facilities primarily consist of residential recovery facilities. It provides a comprehensive continuum of care for adults with addictive disorders and co-occurring mental disorders. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting. It operates in the Healthcare sector (SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC industry).

Acadia Healthcare is currently priced at $31.51, which is close to the average analyst price target of $33. The stock has shown a strong year-to-date change of +120.50%, indicating significant growth. However, the forward P/E ratio is 15.24, suggesting that the stock may be fairly valued at this time. The main risk is the recent downgrade by Raymond James, which reflects limited near-term visibility into earnings, and the stock's recent performance has been volatile, with a -1.16% change yesterday.

17 analysts cover ACHC: 10 rate it Buy, 7 Hold and 0 Sell. The average price target is 18.10.